Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Denosumab
Related studies linked through entity extraction aliases.
RANKL Inhibition and Mammographic Breast Density
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid
- Status
- UNKNOWN
- Phase
- PHASE3
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
- Status
- COMPLETED
- Phase
- PHASE4
Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Markers of Osteoporosis in Cystic Fibrosis
- Status
- RECRUITING
- Phase
- PHASE4
Denosumab Sequential Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Denosumab for Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE1
Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta
- Status
- TERMINATED
- Phase
- PHASE3
RANKL Inhibition and Breast Tissue Biomarkers
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
- Status
- UNKNOWN
- Phase
- PHASE4
Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Denosumab in Subjects With Giant Cell Rich Tumors of Bone
- Status
- UNKNOWN
- Phase
- PHASE2
Denosumab Treatment for Fibrous Dysplasia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies
- Status
- TERMINATED
- Phase
- PHASE3
Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China
- Status
- UNKNOWN
- Phase
- N/A